These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12106843)

  • 1. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.
    Sacks FM;
    Am J Cardiol; 2002 Jul; 90(2):139-43. PubMed ID: 12106843
    [No Abstract]   [Full Text] [Related]  

  • 2. [VA-HIT Study [Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study]].
    Noto H; Kinoshita M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():442-7. PubMed ID: 11347111
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial.
    Robins SJ
    Am J Cardiol; 2001 Dec; 88(12A):19N-23N. PubMed ID: 11788126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niacin after coronary bypass grafting and for coronary disease prevention.
    Parsons WB
    Circulation; 2001 Jul; 104(2):E7. PubMed ID: 11447097
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol lowering as a treatment for established coronary heart disease.
    LaRosa JC; Cleeman JI
    Circulation; 1992 Mar; 85(3):1229-35. PubMed ID: 1346980
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug clinics. How I treat a patient with a low concentration of HDL cholesterol].
    Scheen AJ
    Rev Med Liege; 1998 Dec; 53(12):727-31. PubMed ID: 9927865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: evidence from large-scale statin and fibrate trials.
    Sacks FM
    Am J Cardiol; 2001 Dec; 88(12A):14N-18N. PubMed ID: 11788125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.
    Boden WE; Pearson TA
    Am J Cardiol; 2000 Mar; 85(5):645-50, A10. PubMed ID: 11078282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conclusions from the VA-HIT study.
    Rubins HB; Robins SJ
    Am J Cardiol; 2000 Sep; 86(5):543-4. PubMed ID: 11009274
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemfibrozil prevents major coronary events by increasing HDL-cholesterol and more.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Jul; 2(7):1187-9. PubMed ID: 11583069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing high-density lipoprotein cholesterol: an update on fenofibrate.
    Després JP
    Am J Cardiol; 2001 Dec; 88(12A):30N-36N. PubMed ID: 11788128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low high-density lipoprotein cholesterol and what to do about it.
    Kannel WB
    Am J Cardiol; 1992 Sep; 70(7):810-4. PubMed ID: 1519536
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid disorders.
    Kole LA
    JAAPA; 2009 Nov; 22(11):54-5. PubMed ID: 19999177
    [No Abstract]   [Full Text] [Related]  

  • 14. Taking aim at HDL-C. Raising levels to reduce cardiovascular risk.
    McGovern ME
    Postgrad Med; 2005 Apr; 117(4):29-30, 33-5, 39 passim. PubMed ID: 15842130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levels.
    Havel RJ
    Circulation; 1997 Oct; 96(7):2113-4. PubMed ID: 9337175
    [No Abstract]   [Full Text] [Related]  

  • 16. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.
    Boden WE
    Am J Cardiol; 2000 Dec; 86(12A):19L-22L. PubMed ID: 11374850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol.
    Welty FK; Stuart E; O'Meara M; Huddleston J
    Am J Cardiol; 2002 May; 89(10):1201-4. PubMed ID: 12008176
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of raising high-density lipoprotein cholesterol for prevention of coronary heart disease.
    Teramoto T
    Curr Atheroscler Rep; 2002 Sep; 4(5):327-8. PubMed ID: 12162930
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.